Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results
Olema Pharmaceuticals (NASDAQ:OLMA) shares fell 15. 1% in pre-market trading to $8.
Search
Search covers the most recently published. For the full archive, browsethe topics.
1 result for"Olema"